My last coverage of Crispr Therapeutics (NASDAQ: CRSP ) and Intellia Therapeutics (NASDAQ: NTLA ) was published in May 2025 . At the time, gene therapy stocks were suffering from regulatory uncertainties, potential pricingOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineering, with +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs. As an investor, I have been utilising my background in life sciences to assess the potential o ...

The cybersecurity company CrowdStrike Holdings Inc. (NASDAQ: CRWD) recently saw record attendance at its Fal.Con 2025 conference, and it unveiled a major update to its Falcon platform. ...

Join Now to Access Our Top Picks for November 2025!Your timing is perfect! We’ve just released our latest top investment picks, and by joining today, you’ll gain immediate access to these exciting opportunities. We invest thousands of hours and over $100,000 annually into researching the most profitable investment opportunities—all to bring you high-yield strategies at just a fraction of the cost.Our approach has earned us 190+ five-star reviews from satisfied members who are already seeing the benefits. Do ...

Join Now to Access Our Top Picks for November 2025!Your timing is perfect! We’ve just released our latest top investment picks, and by joining today, you’ll gain immediate access to these exciting opportunities. We invest thousands of hours and over $100,000 annually into researching the most profitable investment opportunities—all to bring you high-yield strategies at just a fraction of the cost.Our approach has earned us 190+ five-star reviews from satisfied members who are already seeing the benefits. Do ...

My last coverage of Crispr Therapeutics (NASDAQ: CRSP ) and Intellia Therapeutics (NASDAQ: NTLA ) was published in May 2025 . At the time, gene therapy stocks were suffering from regulatory uncertainties, potential pricingOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineering, with +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs. As an investor, I have been utilising my background in life sciences to assess the potential o ...

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and b ...

Core Viewpoint - Datavault AI has experienced a significant stock price increase of over 500% in the last 30 days, attracting attention from growth-focused investors [1][2] Group 1: Strategic Developments - The company announced a strategic partnership to launch a digital asset exchange in Switzerland, targeting the Real-World Assets (RWAs) market, projected to exceed $16 trillion by 2030 [3][4] - By collaborating with Swiss corporate advisory firm Max International AG, Datavault AI aims to leverage Switzerland's advanced legal framework for digital assets and Distributed Ledger Technology (DLT), addressing regulatory uncertainties [5] Group 2: Technology and Acquisitions - Datavault AI signed a Letter of Intent to acquire NYIAX, which owns a blockchain-powered trading platform, enhancing its technological capabilities [7][8] - This acquisition allows Datavault AI to bypass the lengthy process of building an exchange from scratch, providing a robust technology engine that meets institutional client demands [8][9] Group 3: Financial Projections - The company has set aggressive revenue guidance for the second half of 2025, projecting between $12 million and $15 million, indicating a significant growth from the $1.74 million reported in the second quarter [10][11] - The current market capitalization of Datavault AI is approximately $473 million, with analysts projecting a price target of $7.00, suggesting substantial upside potential if the company executes its strategic plan [14][15] Group 4: Market Sentiment - The stock's price-to-sales ratio exceeds 177, reflecting high market expectations based on future revenue potential rather than past performance [16] - A notable high short interest in the stock indicates skepticism but also presents a potential bullish catalyst, as successful execution could lead to a short squeeze, driving the stock price higher [17][18]

Consumer-goods giant Procter & Gamble has lowered its estimate for tariff costs in fiscal 2026, while keeping its profit outlook intact. ...

Five things to know ahead of the opening bell. An update on the government shutdown now on day 24. Today, many federal employees are expected to miss their first full paycheck since the shutdown began.We're going to be speaking to House Minority Leader Hakee Jeff at 8:40 a. m. Eastern time.Shares of Intel are rising. The company returning to profitability in its most recent quarter. Revenue of 13.6% 6 billion, beating estimates of 13.1% billion.Fourth quarter guidance was roughly in line with expectations. ...

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/bellring-brands-inc-class-action-lawsuit. Why is BellRing Being Investigated? BellRing Brands operates in the convenient nutrition category. The Compa ...